oral semaglutide cardiovascular benefit Variable weight-loss and benefits were seen with GLP-1 drugs in a systematic review and network meta-analysis, but effects on quality of life were less clear. https://www.medpagetoday.com/primarycare/obesity/122142 Subcutaneous semaglutide demonstrated cardiovascular benefit

For GLP-1-focused probiotics specifically, some suggest taking them before meals might theoretically align with enhancing postprandial GLP-1 secretion, though this remains speculative and is not supported by clinical outcome data

Baltaci, D., Kutlucan, A., Turker, Y., Yilmaz, A., Karacam, S., & Deler, H

A 2025 survey by KFF reported that 27 percent of people taking GLP-1 medications who had health insurance said that they still had to pay the full cost of the drugs out of pocket, however

Initiation of JANUMET XR in patients with an eGFR between 30 and 45 mL/min/1.73 m2 is not recommended

It's important to note that semaglutide may also carry some rare but serious risks

doi: 10.1093/molehr/gay010 Summary Keywords andrology diagnosis, biomarker, assisted reproductive technologies (ART), male infertility, sperm function assay, sperm Citation Nixon B, Schjenken JE, Burke ND, Skerrett-Byrne DA, Hart HM, De Iuliis GN, Martin JH, Lord T and Bromfield EG (2023) New horizons in human sperm selection for assisted reproduction